Arbutus Biopharma Corporation (ABUS)

Etorro trading 970x250
Arbutus Biopharma Corporation (ABUS) Logo

About Arbutus Biopharma Corporation

Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously-delivered RNA interference product candidate, which in an ongoing Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated GalNAc delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company’s research and development programs include HBV RNA destabilizers, an orally active agent to destabilize HBV RNA, which leads to RNA degradation and to reduction in HBV proteins; oral PD-L1 inhibitor to enable reawakening patients’ HBV-specific immune response; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has strategic alliance, licensing, and research collaboration agreements with Marqibo; Gritstone Oncology, Inc.; and Alnylam Pharmaceuticals, Inc. and Acuitas Therapeutics, Inc. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania. Address: 701 Veterans Circle, Warminster, PA, United States, 18974

Arbutus Biopharma Corporation News and around…

Latest news about Arbutus Biopharma Corporation (ABUS) common stock and company :

Arbutus to Report Third Quarter 2021 Financial Results and Provide Corporate Update
21 Oct, 2021 Yahoo! Finance

WARMINSTER, Pa., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a broad portfolio of wholly-owned assets with different mechanisms of action to provide a cure for people with chronic hepatitis B virus (HBV) infection and to treat coronaviruses (including COVID-19), today announced that it has scheduled its third quarter 2021 financial results and corporate

QView Medical in Support of Breast Cancer Awareness Month Joins the Initiative of AmIDense.com
18 Oct, 2021 FinancialContent
21 Stocks Moving in Monday's Pre-Market Session
18 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results ...

10 Top Penny Stocks To Watch This Week With Potential Biotech Catalysts
17 Oct, 2021 FinancialContent
First Week of June 2022 Options Trading For Arbutus Biopharma (ABUS)
15 Oct, 2021 FinancialContent

Investors in Arbutus Biopharma Corp (ABUS) saw new options begin trading this week, for the June 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Arbutus Biopharma (NASDAQ:ABUS) shareholders have earned a 7.3% CAGR over the last five years
13 Oct, 2021 Yahoo! Finance

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...

Best Penny Stocks To Buy This Week? 10 With Potential Biotech Catalysts
10 Oct, 2021 FinancialContent
Why Moderna Stock Is Rebounding Today
07 Oct, 2021 FinancialContent

The company plans to build a new manufacturing facility in Africa.

Thinking about buying stock in Tata Motors, New Fortress Energy, Arbutus Biopharma, US Well Services, or Progenity?
07 Oct, 2021 Yahoo! Finance

InvestorsObserver issues critical PriceWatch Alerts for TTM, NFE, ABUS, USWS, and PROG.

5 Penny Stocks To Watch This Week With Potential Biotech Catalysts
03 Oct, 2021 FinancialContent
Arbutus to Participate in October Investor Conferences
28 Sep, 2021 FinancialContent
Do Options Traders Know Something About Arbutus Biopharma (ABUS) Stock We Don't?
27 Sep, 2021 Yahoo! Finance

Investors need to pay close attention to Arbutus Biopharma (ABUS) stock based on the movements in the options market lately.

Arbutus Appoints Lisa M. Caperelli as Vice President, Investor Relations
21 Sep, 2021 FinancialContent
Interesting ABUS Call Options For January 2024
14 Sep, 2021 FinancialContent

Investors in Arbutus Biopharma Corp (ABUS) saw new options become available this week, for the January 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 857 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

60 Biggest Movers From Friday
13 Sep, 2021 FinancialContent

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported ...

41 Stocks Moving In Friday's Mid-Day Session
10 Sep, 2021 FinancialContent

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
10 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're back at it again with one last day of trading this week and we're kicking it off with Friday's biggest pre-market stock movers. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

20 Stocks Moving in Friday's Pre-Market Session
10 Sep, 2021 FinancialContent

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants ...

48 Biggest Movers From Yesterday
10 Sep, 2021 FinancialContent

Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and ...

Arbutus to Participate in Upcoming Investor Conferences
07 Sep, 2021 FinancialContent
Interesting ABUS Put Options For October 15th
23 Aug, 2021 FinancialContent

Investors in Arbutus Biopharma Corp (ABUS) saw new options become available this week, for the October 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABUS options chain for the new October 15th contracts and identified the following put contract of particular interest.

Is the Options Market Predicting a Spike in Arbutus Biopharma (ABUS) Stock?
23 Aug, 2021 Yahoo! Finance

Investors need to pay close attention to Arbutus Biopharma (ABUS) stock based on the movements in the options market lately.

46 Biggest Movers From Yesterday
19 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on ...

66 Biggest Movers From Yesterday
18 Aug, 2021 FinancialContent

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received ...

Here's What Arbutus Biopharma Corporation's (NASDAQ:ABUS) Shareholder Ownership Structure Looks Like
14 Aug, 2021 Yahoo! Finance

Every investor in Arbutus Biopharma Corporation ( NASDAQ:ABUS ) should be aware of the most powerful shareholder...

Understanding Arbutus Biopharma's Unusual Options Activity
11 Aug, 2021 FinancialContent

Arbutus Biopharma (NASDAQ:ABUS) shares experienced unusual options activity on Wednesday. The stock price moved up to $3.19 following ...

Arbutus Biopharma (ABUS) Q2 2021 Earnings Call Transcript
07 Aug, 2021 FinancialContent

ABUS earnings call for the period ending June 30, 2021.

28 Stocks Moving in Friday's Pre-Market Session
06 Aug, 2021 FinancialContent

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to ...

Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
05 Aug, 2021 Yahoo! Finance

Arbutus (ABUS) delivered earnings and revenue surprises of -9.52% and 12.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
05 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Arbutus Biopharma Corporation (ABUS) is a NASDAQ Common Stock listed in , ,

970x250